GeneDx Holdings (WGSWW) Non-Current Deffered Revenue (2020 - 2021)
GeneDx Holdings (WGSWW) reported Non-Current Deffered Revenue of $295.0 million for Q2 2021, down 0.64% quarter-over-quarter from $297.0 million in Q1 2021.
GeneDx Holdings (WGSWW) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGSWW) has 2 years of Non-Current Deffered Revenue data on file, last reported at $295.0 million in Q2 2021.
- Non-Current Deffered Revenue for Q2 2021 came in at $295.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $295.0 million (changed N/A YoY), and the FY2020 annual result was $132.0 million, changed N/A from the prior year.
- Non-Current Deffered Revenue retreated to $295.0 million in Q2 2021 per WGSWW's latest filing, from $297.0 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $297.0 million in Q1 2021 and troughed at $15.5 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 32.31 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 295.05 Mn |
| Mar 31, 2021 | 296.95 Mn |
| Dec 31, 2020 | 131.99 Mn |
| Sep 30, 2020 | 15.50 Mn |